Parkinson Disease (diet therapy) < Parkinson Disease (drug therapy) < Parkinson Disease (economics)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 464.
[60-80] [0 - 20][0 - 50][80-100]

Ident.	Authors (with country if any)	Title
000272 (2003)	Michael Iskedjian [Canada] ; Thomas R. Einarson	Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease.
000275 (2003)	Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl	Leg muscle strength is reduced in PD and relates to the ability to rise from a chair
000276 (2003)	Jonathan M. Brotchie [Canada]	CB1 cannabinoid receptor signalling in Parkinson's disease.
000278 (2003)	Mark Guttman [Canada] ; Stephen J. Kish ; Yoshiaki Furukawa	Current concepts in the diagnosis and management of Parkinson's disease.
000281 (2003)	J. Carr [Canada] ; R. De La Fuente-Fernández ; M. Schulzer ; E. Mak ; S M Calne ; D B Calne	Familial and sporadic Parkinson's disease usually display the same clinical features.
000282 (2003)	B C L. Lai [Canada] ; M. Schulzer ; S. Marion ; K. Teschke ; J K C. Tsui	The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
000284 (2003)	Frédéric Calon [Canada] ; Marc Morissette ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di Paolo	Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
000291 (2003)	Mahyar Etminan [Canada] ; Sudeep Gill ; Ali Samii	Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease: a meta-analysis.
000293 (2003)	Pierre J. Blanchet [Canada]	The fluctuating Parkinsonian patient--clinical and pathophysiological aspects.
000307 (2003)	Michael Schulzer [Canada] ; Edwin Mak ; Susan M. Calne	The psychometric properties of the Parkinson's Impact Scale (PIMS) as a measure of quality of life in Parkinson's disease.
000308 (2003)	D. Coyle [Canada] ; M. Barbeau ; M. Guttman ; J-F Baladi	The economic evaluation of pharmacotherapies for Parkinson's disease.
000311 (2003)	Penka Petrova [Canada] ; Andrei Raibekas ; Jonathan Pevsner ; Noel Vigo ; Mordechai Anafi ; Mary K. Moore ; Amy E. Peaire ; Viji Shridhar ; David I. Smith ; John Kelly ; Yves Durocher ; John W. Commissiong	MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons.
000322 (2003)	Ajit Kumar [Canada] ; Sharanpal Mann ; Vesna Sossi ; Thomas J. Ruth ; A Jon Stoessl ; Michael Schulzer ; Chong S. Lee	[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease.
000326 (2003)	A Jon Stoessl [Canada]	Agonizing over dopaminergic replacement therapy--lessons from animal models of Parkinson's disease.
000333 (1992)	H A Robertson [Canada]	Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease: sites of action and implications for the pathogenesis of dyskinesias.
000334 (1992)	D B King [Canada]	The place of the dopaminergic agonists in the treatment of Parkinson's disease: the view from the trenches.
000335 (1992)	E. Pourcher [Canada] ; B. Gomez-Mancilla ; P J Bédard	Ethosuximide and tremor in Parkinson's disease: a pilot study.
000342 (1992)	H A Robertson [Canada]	Dopamine receptor interactions: some implications for the treatment of Parkinson's disease.
000355 (????)	Simon Lemay [Canada] ; Pierre Blanchet ; Sylvain Chouinard ; Hélène Masson ; Valérie Soland ; Marc-André Bédard	Poor tolerability of a transdermal nicotine treatment in Parkinson's disease.
000378 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire ; Abdallah Hadj Tahar ; Paul J. Bédard	Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys.
000380 (2003)	Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di Paolo	Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (drug therapy)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022